Search results
Results From The WOW.Com Content Network
It also contains 237 million bioactivity test results from 1.25 million biological assays, covering >10,000 target protein sequences. [ 4 ] As of 2020, with data integration from over 100 new sources, PubChem contains more than 293 million depositor-provided substance descriptions, 111 million unique chemical structures, and 271 million ...
Pharmacode, also known as Pharmaceutical Binary Code, is a barcode standard, used in the pharmaceutical industry as a packing control system. It is designed to be readable despite printing errors. It can be printed in multiple colors as a check to ensure that the remainder of the packaging (which the pharmaceutical company must print to protect ...
Title 11 of the United States Code. Harrington v. Purdue Pharma L.P., 603 U.S. ___ (2024), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. [ 1 ] This case is about the settlement by Purdue Pharma for opioid victims who overdosed with the OxyContin drug produced by the company.
The certificate of pharmaceutical product (abbreviated: CPP) is a certificate issued in the format recommended by the World Health Organization (WHO), which establishes the status of the pharmaceutical product and of the applicant for this certificate in the exporting country; [1] it is often mentioned in conjunction with the electronic Common Technical Document (eCTD).
The Pharma Letter (or TPL), is an English pharmaceutical, generics and biotechnology news and analysis service. [1]
Innovative Medicines Canada (IMC) is a national association of pharmaceutical companies that represents the interests of the research-based pharmaceutical industry in Canada. Its membership includes biopharmaceutical companies, vaccine developers, and manufacturers of medical devices, and works with government agencies, insurance companies ...
Loaded 0%. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers ...
On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., [1] a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry and neurology, oncology, urology, women's health, rare disease, and cell and gene therapies.